Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
University Health Network, Toronto
University of California, San Diego
Akeso
Instituto Nacional de Cancer, Brazil
National Cancer Institute, Naples
Ruhr University of Bochum
Royal Marsden NHS Foundation Trust
Yonsei University
Amgen
Amgen
Rigshospitalet, Denmark
Shenzhen SiBiono GeneTech Co.,Ltd
Stanford University
Sun Yat-sen University
National Cancer Institute (NCI)
University of Arkansas
Gachon University Gil Medical Center